Genitourinary Cancer
Approaches to Urothelial Care Call for Nuanced AE Management
August 11, 2022
Article
Avelumab, erdafitinib, and enfortumab vedotin-ejfv are 3 critical drugs in the treatment of urothelial cancer with distinct safety profiles, according to a presentation at the 6th Annual School of Nursing Oncology™ Meeting.
N-803 BLA Undergoes Review For BCG-Unresponsive Non–Muscle Invasive Bladder Cancer in Situ
August 10, 2022
Article
A biologics license application for the IL-15 superagonist N-803 has been accepted and the agent will be reviewed for the treatment of patients with Bacillus Calmette-Guérin–unresponsive non–muscle invasive bladder cancer carcinoma in situ.
Evolution of Frontline VEGF TKI/Immunotherapy Treatments Propels Field of Renal Cell Carcinoma
August 10, 2022
Article
In a presentation at the 6th Annual School of Nursing Oncology™, Laura Wood, RN, MSN, OCN, highlights key nurse takeaways with VEGF TKI/immune checkpoint inhibitor therapy for patients with renal cell carcinoma.
FDA Approves Darolutamide Tablets for Select Patients With Prostate Cancer
August 08, 2022
Article
Patients with hormone-sensitive prostate cancer who received darolutamide in combination with docetaxel experienced superior overall survival and time-to-pain progression benefit.
Oncology Nursing News Top Stories: July 2022
July 29, 2022
Article
Each month, we take a look back at the most popular Oncology Nursing News® stories. Here are the top 5 stories from July 2022.
ESMO Guideline on Liquid Biopsy Address Quality Standards for Clinical Implementation
July 27, 2022
Article
In early-stage cancers, ctDNA has a role in screening, neoadjuvant monitoring, identification of molecular residual disease (MRD), molecular relapse monitoring, and early assessment of treatment response.
Uniform Baseline Measurements Are Crucial in Improving Standard of Supportive Care
July 26, 2022
Article
Lidia Schapira, MD, FASCO, discusses the importance of rigorous baseline measurement in improving the assessment and management of distressful cancer symptoms.
Key Advances in Cancer Survivorship Toxicity Management
July 15, 2022
Podcast
In this episode of The Vitals, Lidia Schapira, MD, FASCO, recounts highlights from the 2022 ASCO Symptoms and Survivorship track and underscores key takeaways for practitioners seeking to enhance the delivery of cancer survivorship care.
Burbage Provides Nursing Perspective on 2022 ASCO Meeting
July 01, 2022
Article
Darcy Burbage, DNP, RN, AOCN, CBCN, discusses the top takeaways from the 2022 ASCO Annual Meeting for oncology nurses.
Oncology Nursing News’ Top ASCO Picks
June 28, 2022
Article
We rounded up 5 stories from the 2022 ASCO Annual Meeting that are of most value to oncology nurses.